In the retrospective series by Brodska et al., high PD-L1 expression in AML blasts predicted inferior survival outcomes, though this negative prognostic impact was limited to the patient subgroup affected with NPM1-mutated AML showing concurrent FLT3-ITD [71]. This evidence concerns the gene CD274 and acute myeloid leukemia.